Effectiveness of telemedicine: a systematic review of reviews.
Anne G Ekeland, Alison Bowes, Signe Flottorp
https://pubmed.ncbi.nlm.nih.gov/20884286/Actively Recruiting
Led by Federal University of Bahia · Updated on 2025-08-12
194
Participants Needed
1
Research Sites
12 weeks
Total Duration
Researchers are evaluating the effectiveness of a pharmaceutical care protocol delivered via teleconsultation compared to in-person pharmaceutical care in managing uncontrolled hypertension in elderly patients. This study aims to understand how well telepharmacy supports clinical outcomes and treatment adherence for older adults with high blood pressure. It also explores patient satisfaction and the clinical impact of pharmacist interventions. Participants will be randomly assigned to receive either pharmaceutical care through telepharmacy or traditional in-person care. The study involves four visits two visits for initial and final assessments of clinical parameters and application of instruments, conducted in a pharmacy setting by trained pharmacists and students and two visits for pharmaceutical consultations, which will be either teleconsultations or face-to-face sessions, depending on group assignment. During the study, researchers will measure blood pressure control, medication adherence, patient satisfaction, and the clinical significance of pharmacist interventions over a three-month period. Participants will have their blood pressure measured using a standardized protocol, and their treatment adherence and satisfaction will be evaluated. The study is sponsored by the Federal University of Bahia and is expected to complete by March 2026.
CONDITIONS
Telepharmacy on Patients With Arterial Hypertension
G
Gabriella F Magalhães
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Federal University of Bahia
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) to assess eligibility and baseline blood pressure
Duration - 3 months
Participants receive pharmaceutical care either via telepharmacy or in-person pharmacotherapeutic monitoring along with usual care.
Regular telephone or in-person consultations during the 3 months
Duration - Up to end of the 3rd month
Participants' adherence to medication, satisfaction with care, and clinical outcomes are evaluated after the treatment period.
Assessments conducted at the end of the treatment period
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Anne G Ekeland, Alison Bowes, Signe Flottorp
https://pubmed.ncbi.nlm.nih.gov/20884286/Mackenzie Williams, Gregory M Peterson, Peter C Tenni...
https://pubmed.ncbi.nlm.nih.gov/22101425/Karen L Margolis, Stephen E Asche, Anna R Bergdall...
https://pubmed.ncbi.nlm.nih.gov/23821088/Yousuf Gandapur, Sina Kianoush, Heval M Kelli...
https://pubmed.ncbi.nlm.nih.gov/29474713/Julia Amkreutz, Rebekka Lenssen, Gernot Marx...
https://pubmed.ncbi.nlm.nih.gov/30253681/A Al Hamid, M Ghaleb, H Aljadhey...
https://pubmed.ncbi.nlm.nih.gov/25239295/Emily Alexander, C David Butler, Andrea Darr...
https://pubmed.ncbi.nlm.nih.gov/28438829/Nishat Afreen, Eimeira Padilla-Tolentino, Brandy McGinnis
https://pubmed.ncbi.nlm.nih.gov/34007681/Roy Freeman, Wouter Wieling, Felicia B Axelrod...
https://pubmed.ncbi.nlm.nih.gov/21431947/Beverly B Green, Andrea J Cook, James D Ralston...
https://pubmed.ncbi.nlm.nih.gov/18577730/Federal University of Bahia
Lead Sponsor